Pioglitazone

In medicine and pharmacology, pioglitazone is a member of the drug class of the thiazolidinediones.

It is being marketed as Actos® by the pharmaceutical companies Takeda and Eli Lilly.

Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.

Table of contents

1 Side-effects and contraindications 2 See also 3 External links

Side-effects and contraindications

See main article: thiazolidinedione

See also

• Anti-diabetic drugs
• Peroxisome proliferator-activated receptor

External links

• MedlinePlus article on pioglitazone.
• Diabetes monitor on Pioglitazone
• Actos / Pioglitazone Fact Sheet